Medtronic Revenue and Competitors
Estimated Revenue & Valuation
- Medtronic's estimated annual revenue is currently $31.8B per year.
- Medtronic's estimated revenue per employee is $290,204
- Medtronic's total funding is $367M.
- Medtronic's current valuation is $146B. (January 2022)
Employee Data
- Medtronic has 109578 Employees.
- Medtronic grew their employee count by 4% last year.
Medtronic's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Group CFO and VP Finance, Restorative Therapies Group | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Executive Assistant to VP Legal Asia and Japan / ANZ | Reveal Email/Phone |
4 | Chief Counsel, Coronary & Renal Denervation, Cardiovascular Portfolio | Reveal Email/Phone |
5 | Chief Counsel | Reveal Email/Phone |
6 | Regional VP Sales, Spine & Enabling Technologies | Reveal Email/Phone |
7 | Area VP Sales - Southeast | Reveal Email/Phone |
8 | Area VP Sales, Medtronic Spine - South | Reveal Email/Phone |
9 | VP | Reveal Email/Phone |
10 | Executive Assistant to President, Emerging Markets | Reveal Email/Phone |
Medtronic Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $42310M | 169995 | 5% | N/A | $226.6B |
#2 | $68.5M | 273 | N/A | N/A | N/A |
#3 | $19670M | 176108 | N/A | N/A | $30.3B |
#4 | $27.3M | 109 | N/A | N/A | N/A |
What Is Medtronic?
Medtronic, Inc. is a medical technology company that provides lifelong solutions for people with chronic disease. The Company offers therapies to restore patients worldwide to fuller, healthier lives. Medtronic\'s primary products are used for bradycardia pacing, tachyarrhythmia management, atrial fibrillation, heart failure, coronary and peripheral vascular disease, minimally invasive cardiac surgery, heart valve replacement, extracorporeal cardiac support, spinal and neurosurgery,malignant and non-malignant pain, movement disorders, neurodegenerative disorders, and ear, nose and throat (ENT) surgery. Medtronic conducts business through four units: Cardiac Rhythm Management; Vascular; Cardiac Surgery; and Neurological, Spinal and ENT.
keywords:Biotechnology, Medical Devices
$367M
Total Funding
109578
Number of Employees
$31.8B
Revenue (est)
4%
Employee Growth %
$146B
Valuation
N/A
Accelerator
Medtronic News
Shares of Medtronic PLC MDT, -4.68% slid 4.68% to $107.80 Friday, on what proved to be an all-around rough trading session for the stock...
Medtronic (NYSE:MDT) today said its Symplicity Spyral renal denervation (RDN) system demonstrated durable, clinically significant blood...
Fridley, Minnesota-based Medtronic's Titan 2 trial will evaluate the safety and efficacy of the company's implantable tibial neuromodulation (...
Medtronic, the world’s largest medical device company, is significantly increasing its investments into AI and other technologies, in what it says is an effort to help the health care industry catch up with other industries. While many other industries have embraced technology, health care has ...
DUBLIN, Sept. 30, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine spinal implants, biologics, navigation, robotics, and AI-powere ...